K-PEARL
LIVE

Serial Number

79446182

Owner

Samsung Biologics Co., Ltd.

Filing Date

Feb 9, 2026

Add to watchlist:

No watchlists yet
View on USPTO

K-PEARL Trademark

Serial Number: 79446182

K-PEARL is a trademark filed by Samsung Biologics Co., Ltd. on February 9, 2026. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Samsung Biologics Co., Ltd. (26 trademarks)

300, Songdo bio-daero,

Entity Type: 03

Trademark Details

Filing Date

February 9, 2026

Registration Date

Not Registered

Goods & Services

Custom manufacture of biopharmaceuticals; processing of medicinal materials; custom manufacture of pharmaceuticals; preservation of pharmaceuticals; processing of pharmaceuticals; processing of chemicals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; chemical treatment of liquids; custom manufacture of cell lines for biopharmaceutical manufacturing; custom manufacture of specific antibody-binding glycosylated drugs.

Science laboratory services for high-efficiency glycan analysis; culturing of cells for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid analysis; protein analysis; toxicity analysis; molecular analysis; development of biotechnology; biotechnology research; biological analysis; biological research; research of biologics; biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; genetics research; computer programming in the medical field; medical laboratories; computer software technical support service relating to management support of medical image data; medicine research; analysis and evaluation of medical product development; providing information on the testing, inspection and research of medical products; evaluating of clinical trial progress; clinical trials.

Advertising and commercial information services; business administration and office work; marketing services; demonstration of goods; import-export agency services; business advice for companies relating to medical services and healthcare; collection of electronic data for business purposes in the field of medicine and healthcare; on-line wholesale store services featuring pharmaceuticals; on-line retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; presentation of goods on communication media, for retail purposes; providing consumer product information via the Internet; promoting the goods and services by means of operating an on-line comprehensive shopping mall; electronic data processing services relating to health care information; accountancy advice; health care cost management; statistical analysis, data evaluation and preparation of business reports relating thereto in the field of healthcare.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 7, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jun 6, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 20, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 19, 2026 REPR